Alliance Pharma (APH)

 

Latest News

Acquisitions to boost Alliance Pharma prospects, says Hardman

Hardman Research has issued a report on Alliance Pharma. It says: 'Alliance Pharma is continuing with its buy-and-build ...

Hardman Research: Acquisitions to boost growth

RNS Number: 5498B Alliance Pharma PLC 11 January 2018 Hardman Research: Acquisitions to boost growth prospects Acquisitions to boost growth prospects - Alliance Pharma is continuing with its buy-and-build strategy, having evolved through 35 acquisitions over a period of 20 years into a profitable, cash generative, specialty pharma business. The company has a...

Total Voting Rights

RNS Number: 7423A Alliance Pharma PLC 02 January 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Total Voting Rights Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 29 December ...

Block Listing Six Monthly Return

RNS Number: 6116A Alliance Pharma PLC 02 January 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Group") Block Listing Six Monthly Return Name of applicant: ALLIANCE PHARMA PLC Names of schemes: a) The Alliance Pharma plc Approved Share Option Plan 2005 b) The Alliance Pharma plc Share Option Plan 2006 c) The Alliance Pharma plc Com...

All News

DateHeadlineSource
11-01-18Acquisitions to boost Alliance Pharma prospects, says Hardman StockMarketWire
11-01-18Hardman Research: Acquisitions to boost growthRNS
02-01-18Total Voting RightsRNS
02-01-18Block Listing Six Monthly ReturnRNS
28-12-17Alliance Pharma completes Vamousse deal StockMarketWire
28-12-17Completion of acquisition of VamousseRNS
22-12-17Block Listing Six Monthly ReturnRNS
12-12-17Broker Forecast - finnCap issues a broker note on Alliance Pharma PLCStockMarketWire
04-12-17Broker Forecast - Numis issues a broker note on Alliance Pharma PLCStockMarketWire
04-12-17Alliance to acquire rights to Vamousse StockMarketWire
04-12-17Tender Offer to Shareholders and Notice of MeetingRNS
04-12-17Proposed acquisition of VamousseRNS
01-12-17Broker Forecast - Numis issues a broker note on Alliance Pharma PLCStockMarketWire
01-12-17Alliance acquires Ametop rights for $7.5mStockMarketWire
01-12-17Acquisition of AmetopTRNS
17-10-17Alliance Pharma building international sales, says Hardman StockMarketWire
17-10-17Hardman Research: Kelo-cote international salesRNS
13-09-17Alliance Pharma revenues and earnings rise StockMarketWire
13-09-17Interim ResultsRNS
06-09-17Appointment of Joint Corporate BrokerRNS
01-08-17Notification of Interim ResultsRNS
31-07-17Broker Forecast - finnCap issues a broker note on Alliance Pharma PLCStockMarketWire
28-07-17Update on DiclectinRNS
25-07-17Changes to interests of a significant shareholderRNS
25-07-17Changes to interests of a significant shareholderRNS
18-07-17Half Year Trading UpdateRNS
13-07-1710 'crisis-proof' shares to buy and hold foreverMoney Observer
03-07-17Changes to interests of a significant shareholderRNS
26-06-17Changes to interests of a significant shareholderRNS
22-06-17Changes to interests of a significant shareholderRNS
21-06-17Application for block admissionRNS
19-06-17Changes to interests of a significant shareholderRNS
19-06-17Application for admissionRNS
14-06-17Application for admissionRNS
25-05-17Changes to interests of a significant shareholderRNS
25-05-17Result of AGMRNS
25-05-17Alliance Pharma cash flow remains strong StockMarketWire
25-05-17Hardman Res.: Transformed International BusinessRNS
25-05-17AGM StatementRNS
22-05-17Application for admissionRNS

RSS feeds

  • Editorial news feed for LSE:APH Editorial
  • Regulatory news feed for LSE:APH Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account